A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
Clinical trial NCT03433677 · COMPLETED
Trial details
- NCT number
- NCT03433677
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2018-09-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.